These results suggest a role for KLF3 in predicting immunotherapeutic response in pan-cancer and predicting effective small molecule drugs targeting KLF3, which may provide strong evidence for future pan-cancer therapeutic studies. This evidence concerns the gene KLF3 and cancer.